Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Jefferies Financial
JEF
5
Amazon
AMZN
HK Stock MarketDetailed Quotes
02096 SIMCERE PHARMA
- 8.730
- +0.080+0.92%
Market Closed Apr 29 16:08 CST
21.71BMarket Cap27.45P/E (TTM)
8.950High8.650Low4.78MVolume8.710Open8.650Pre Close42.00MTurnover0.19%Turnover Ratio27.45P/E (Static)2.49BShares9.06052wk High2.84P/B21.71BFloat Cap5.08052wk Low0.18Dividend TTM2.49BShs Float14.453Historical High0.184Dividend LFY3.47%Amplitude4.764Historical Low8.792Avg Price1000Lot Size2.11%Div YieldTTM2.11%Div Yield LFY
SIMCERE PHARMA Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 0.41%6.64B | -7.93%3.11B | 4.49%6.61B | 25.26%3.38B | 26.49%6.32B | 27.34%2.7B | 10.89%5B | 10.11%2.12B | -10.48%4.51B | -20.24%1.93B |
| Operating income | 0.41%6.64B | -7.93%3.11B | 4.49%6.61B | 25.26%3.38B | 26.49%6.32B | 27.34%2.7B | 10.89%5B | 10.11%2.12B | -10.48%4.51B | -20.24%1.93B |
| Cost of sales | 19.28%-1.31B | 20.57%-651.59M | -22.32%-1.62B | -47.18%-820.36M | -22.91%-1.33B | -21.97%-557.37M | -20.01%-1.08B | -17.74%-456.98M | -1.29%-899.93M | 9.41%-388.13M |
| Operating expenses | 19.28%-1.31B | 20.57%-651.59M | -22.32%-1.62B | -47.18%-820.36M | -22.91%-1.33B | -21.97%-557.37M | -20.01%-1.08B | -17.74%-456.98M | -1.29%-899.93M | 9.41%-388.13M |
| Gross profit | 6.83%5.32B | -3.88%2.46B | -0.25%4.98B | 19.56%2.56B | 27.47%5B | 28.82%2.14B | 8.62%3.92B | 8.18%1.66B | -13.00%3.61B | -22.58%1.54B |
| Selling expenses | -6.56%-2.51B | 7.36%-1.16B | 1.93%-2.36B | -21.19%-1.25B | -17.97%-2.4B | -23.99%-1.03B | -29.70%-2.04B | -32.09%-830.18M | 22.11%-1.57B | 39.38%-628.5M |
| Administrative expenses | -5.36%-526.04M | 10.36%-230.81M | -11.93%-499.28M | -36.60%-257.47M | -21.66%-446.08M | -15.29%-188.48M | 10.89%-366.66M | 15.50%-163.48M | -17.00%-411.48M | -24.33%-193.46M |
| Research and development expenses | 9.79%-1.41B | 27.04%-566.13M | 9.56%-1.56B | -19.09%-775.89M | -21.99%-1.73B | -3.95%-651.54M | -24.06%-1.42B | -38.03%-626.8M | -59.40%-1.14B | -79.82%-454.09M |
| Impairment and provision | 689.16%6.84M | 94.36%1.83M | -93.79%867K | -95.31%939K | 188.27%13.97M | 150.54%20.03M | ---15.83M | ---39.63M | ---- | ---- |
| -Other impairment is provision | 689.16%6.84M | 94.36%1.83M | -93.79%867K | -95.31%939K | 188.27%13.97M | 150.54%20.03M | ---15.83M | ---39.63M | ---- | ---- |
| Special items of operating profit | -124.83%-36.15M | -100.94%-19.04M | -65.91%145.59M | 905.89%2.03B | -68.71%427.08M | -145.53%-251.85M | 208.84%1.36B | 1,410.37%553.17M | 311.26%441.89M | -28.17%36.63M |
| Operating profit | 19.14%848.05M | -78.70%492.16M | -17.29%711.8M | 5,521.48%2.31B | -40.59%860.61M | -92.61%41.11M | 56.29%1.45B | 86.71%556.11M | -20.87%926.84M | -49.65%297.85M |
| Financing income | -28.63%39.23M | -17.86%25.41M | -8.20%54.96M | 2.23%30.94M | -12.33%59.87M | 8.02%30.26M | 160.16%68.29M | 158.17%28.01M | -24.41%26.25M | -56.40%10.85M |
| Financing cost | -101.22%-69.56M | -29.26%-23.47M | -0.47%-34.57M | 1.93%-18.16M | 51.43%-34.41M | 60.94%-18.51M | 47.02%-70.85M | 40.44%-47.4M | -15.33%-133.73M | -22.78%-79.58M |
| Share of profits of associates | -128.03%-1.63M | 102.27%18K | 4,963.48%5.82M | -104.91%-793K | 100.26%115K | 97.38%-387K | -216.53%-43.92M | -238.85%-14.75M | -70.67%-13.87M | -186.76%-4.35M |
| Share of profit from joint venture company | 87.73%3.79M | -51.69%573K | 2,594.67%2.02M | 2,137.74%1.19M | 127.78%75K | 139.55%53K | 31.30%-270K | -235.00%-134K | -191.11%-393K | ---40K |
| Earning before tax | 10.79%819.88M | -78.72%494.69M | -16.50%740.04M | 4,325.15%2.32B | -36.78%886.25M | -89.94%52.52M | 74.12%1.4B | 132.20%521.84M | -25.58%805.09M | -59.15%224.73M |
| Tax | -232.39%-86.71M | 25.81%-38.09M | -164.45%-26.09M | -646.35%-51.35M | -58.32%40.48M | -71.57%9.4M | 168.98%97.12M | 182.85%33.06M | -80.07%-140.8M | 55.24%-39.9M |
| After-tax profit from continuing operations | 2.69%733.17M | -79.91%456.6M | -22.96%713.95M | 3,570.60%2.27B | -38.17%926.73M | -88.84%61.92M | 125.64%1.5B | 200.21%554.9M | -33.81%664.29M | -59.91%184.84M |
| Earning after tax | 2.69%733.17M | -79.91%456.6M | -22.96%713.95M | 3,570.60%2.27B | -38.17%926.73M | -88.84%61.92M | 125.64%1.5B | 200.21%554.9M | -33.81%664.29M | -59.91%184.84M |
| Minority profit | ---- | ---- | 80.39%-811K | 56.47%-811K | 49.41%-4.14M | 36.18%-1.86M | -55.80%-8.18M | -327.38%-2.92M | ---5.25M | ---683K |
| Profit attributable to shareholders | 2.57%733.17M | -79.92%456.6M | -23.22%714.76M | 3,464.66%2.27B | -38.23%930.87M | -88.57%63.78M | 125.10%1.51B | 200.68%557.81M | -33.29%669.53M | -59.76%185.52M |
| Basic earnings per share | 7.41%0.29 | -79.31%0.18 | -25.00%0.27 | 4,250.00%0.87 | -37.93%0.36 | -90.48%0.02 | 107.14%0.58 | 162.50%0.21 | -34.88%0.28 | -60.00%0.08 |
| Diluted earnings per share | 7.41%0.29 | -79.07%0.18 | -25.00%0.27 | 4,200.00%0.86 | -37.93%0.36 | -90.48%0.02 | 107.14%0.58 | 162.50%0.21 | -34.88%0.28 | -60.00%0.08 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | -- | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts